In vitro activity of voriconazole against Candida species isolated in Taiwan.
暂无分享,去创建一个
[1] C. Hsiao,et al. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. , 2003, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[2] H. Lo,et al. Factors accounting for misidentification of Candida species. , 2001, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[3] Yun-Liang Yang,et al. Mechanisms of antifungal agent resistance. , 2001, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[4] T. C. White,et al. Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans , 2001, Antimicrobial Agents and Chemotherapy.
[5] J. Peter,et al. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. , 2000, The Journal of antimicrobial chemotherapy.
[6] I. Trocóniz,et al. Comparative Pharmacokinetics, Tissue Distributions, and Effects on Renal Function of Novel Polymeric Formulations of Amphotericin B and Amphotericin B-Deoxycholate in Rats , 2000, Antimicrobial Agents and Chemotherapy.
[7] R. Schwartz,et al. Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors , 2000, Antimicrobial Agents and Chemotherapy.
[8] M. Ghannoum,et al. Mechanism of Fluconazole Resistance inCandida krusei , 1998, Antimicrobial Agents and Chemotherapy.
[9] Ronald N. Jones,et al. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. , 1998, Diagnostic microbiology and infectious disease.
[10] M. Nettleman,et al. Secular Trends in the Epidemiology of Nosocomial Fungal Infections at a Teaching Hospital in Taiwan, 1981 to 1993 , 1997, Infection Control & Hospital Epidemiology.